Recombinant fibrinogen Vlissingen/Frankfurt IV - The deletion of residues 319 and 320 from the gamma chain of fibrinogen alters calcium binding, fibrin polymerization, cross-linking and platelet aggregation
Ka. Hogan et al., Recombinant fibrinogen Vlissingen/Frankfurt IV - The deletion of residues 319 and 320 from the gamma chain of fibrinogen alters calcium binding, fibrin polymerization, cross-linking and platelet aggregation, J BIOL CHEM, 275(23), 2000, pp. 17778-17785
We synthesized a variant, recombinant fibrinogen modeled after the heterozy
gous dysfibrinogen Vlissingen/Frankfurt IV, a deletion of two residues, gam
ma Asn-319 and gamma Asp-320, located within the high affinity calcium-bind
ing pocket. Turbidity studies showed no evidence of fibrin polymerization,
although size exclusion chromatography, transmission electron microscopy, a
nd dynamic light scattering studies showed small aggregates. These aggregat
es did not resemble normal protofibrils nor did they clot. Fibrinopeptide A
release was normal, whereas fibrinopeptide B release was delayed approxima
tely 3-fold. Plasmin cleavage of this fibrinogen was not changed by the pre
sence of calcium or Gly-Pro-Arg-Pro, indicating that both the calcium-bindi
ng site and the "a" polymerization site were non-functional. We conclude th
at the loss of normal polymerization was due to the lack of "A-a" interacti
ons. Moreover, functions associated with the C-terminal end of the gamma ch
ain, such as platelet aggregation and factor XIII cross-linking, were also
disrupted, suggesting that this deletion of two residues affected the overa
ll structure of the C-terminal domain of the gamma chain.